Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Expression Profile of Long Non-Coding RNAs in Serum of Patients with Multiple Sclerosis.
Changes in Synaptic Transmission and Long-term Potentiation Induction as a Possible Mechanism for Learning Disability in an Animal Model of Multiple Sclerosis.
Comparative study of the efficacy of limaprost and pregabalin as single agents and in combination for the treatment of lumbar spinal stenosis: a prospective, double blind, randomized controlled non-inferiority trial.
RAD001 (everolimus) attenuates experimental autoimmune neuritis by inhibiting the mTOR pathway, elevating Akt activity and polarizing M2 macrophages.
Bevacizumab is safe in acute relapses of neuromyelitis optica.
Therapeutic options in neuromyelitis optica spectrum disorders.
A tetramethoxychalcone from Chloranthus henryi suppresses lipopolysaccharide-induced inflammatory responses in BV2 microglia.
Effects of severe spasticity treatment with intrathecal Baclofen in multiple sclerosis patients: Long term follow-up.
3D+t Brain MRI segmentation using robust 4D Hidden Markov Chain.
Will CSF biomarkers guide future therapeutic decisions in multiple sclerosis?
Meta-analysis of the IL23R and IL12B polymorphisms in multiple sclerosis.
miFRame: analysis and visualization of miRNA sequencing data in neurological disorders.
Relevance of quality of life assessment for multiple sclerosis patients with memory impairment.
Lesional accumulation of CD8(+) cells in sciatic nerves of experimental autoimmune neuritis rats.
IL-21R signaling is critical for induction of spontaneous experimental autoimmune encephalomyelitis.
Prevalence of neuropathic pain in early multiple sclerosis.
Translational utility of experimental autoimmune encephalomyelitis: recent developments.
Acute Disseminated Encephalomyelitis After Human Parechovirus Infection.
Tropisetron diminishes demyelination and disease severity in an animal model of multiple sclerosis.
The cost of medication and the cost of treatment are not the same thing for multiple sclerosis.
Emerging injectable therapies for multiple sclerosis.
Validating a novel web-based method to capture disease progression outcomes in multiple sclerosis.
Consensus guidelines on the neurologist's role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosis.
Low contrast visual acuity testing is associated with cognitive performance in multiple sclerosis: a cross-sectional pilot study.
Quantifying Demyelination in NK venom treated nerve using its electric circuit model.
Pages
« first
‹ previous
…
604
605
606
607
608
609
610
611
612
…
next ›
last »